Document is current

Any future updates will be listed below

Correction to: Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”

Crossref DOI link: https://doi.org/10.1007/s40261-022-01233-8

Published Online: 2022-12-02

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark